Among drug store buy sleeping factors driving the drop, he says, are fewer kola launches, fear of government sleeping pills regulation and cuts by a few brands that had spent big. Results sho that direct-to-consumer (DTC) ads "probably aren't as effective as widely perceived," says Hamish Law, lead That bodes ill for the magazines, newspapers and radio and TV outlets for which the ads have been a prescription sleeping pills for profits. prescription medication no Enbrel (for rheumatoid arthritis), Nasonex (nasal allergies) and Zelnorm (irritable bowel syndrome). Some major brands, such as Pfizer's Lipitor, have revamped ads under government pressure. A service of rozerem 8 mg YellowBrix, Inc.. The reports follow prescription sleeping pills ultram a well-publicized Harvard Medical School study that found consumer ads had little effect on prescription drug sales.
Two recent reports say drugmakers cut Rx ad spending in the first six months of this rozerem 8 mg year. "The pharmaceutical companies perceive the threat of government regulation on marketing to be a stronger threat now than it has been in the past," and are trying to self-regulate, Swallen says. Rival ad tracker Nielsen Monitor-Plus calculates the decline at 4.8% to $2.7 billion. Researchers focused on ads for three rozerem generic drugs. Magazines and radio stations have seen the most drug ad decline. Those declines are an abrupt reversal from the robust spending growth of a few years ago.
$175million in that quarter in 2007. Pharmaceutical ad spending they count on ramelteon to exceed $5 billion a year is losing its potency. The site encourages consumers to keep an eye out for false or misleading ads and provides a tommy to report violators.
(c) 2008 USA TODAY, a division of Gannett Co. It launched a "Be Smart about Prescription Drug Advertising" area online at. Second-quarter spending in magazines fell 29% to $358million, according to TNS, while radio plummeted 62% to $4million. And it comes as they already are dealing with large spending declines in some other major ad categories, such as automotive and telecommunications, and recession fears, thanks to the crisis on Wall Street. Takeda Pharmaceuticals North America's Rozerem sleep aid, which used offbeat ad characters such as Fons Alphonso and a beaver, cut spending from $91million in the first half of 2007 to $15million in the first half this year.
By Twyla Petrecca NEW YORK -- This could make media owners sick. "Throughout much of the early decade, it was growing at strong double-digit rates as pharmaceutical marketers become more comfortable and experienced with DTC advertising," says Jon Swallen, TNS senior vice president of research. Sepracor's Lunesta, an insomnia drug known for its glowing moth icon, spent $75million on ads in the first quarter of 2008 vs. That if the government gets involved, they'll be worse off." Last month, the Food and Drug Administration stepped up its watch by asking consumers to help watch for false or misleading drug ads. TNS Media Intelligence puts the vegetable remedies at 3.9% to $2.4 billion.
.